Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis study.

Lorenzo C, Wagenknecht LE, Karter AJ, Hanley AJ, Rewers MJ, Haffner SM.

Diabetes Care. 2011 Sep;34(9):1959-64. doi: 10.2337/dc10-2120. Epub 2011 Jul 25.

PMID:
21788626
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.

Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM.

Diabetes. 2006 Apr;55(4):1114-20.

PMID:
16567536
[PubMed - indexed for MEDLINE]
Free Article
4.

Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.

Festa A, Haffner SM, Wagenknecht LE, Lorenzo C, Hanley AJ.

J Clin Endocrinol Metab. 2013 Oct;98(10):4152-9. doi: 10.1210/jc.2013-1937. Epub 2013 Jul 24.

PMID:
23884776
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

Diabetes Care. 1997 Oct;20(10):1562-8.

PMID:
9314636
[PubMed - indexed for MEDLINE]
6.

Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.

PMID:
12582008
[PubMed - indexed for MEDLINE]
Free Article
7.

Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study.

Watkins SM, Rowe MW, Kolberg JA, Wagenknecht LE, Bergman RN.

Diabet Med. 2012 Nov;29(11):1399-406. doi: 10.1111/j.1464-5491.2012.03625.x.

PMID:
22413950
[PubMed - indexed for MEDLINE]
8.

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Diabetes Care. 2003 Mar;26(3):868-74.

PMID:
12610051
[PubMed - indexed for MEDLINE]
9.

Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

Diabetes. 2004 Jun;53(6):1549-55.

PMID:
15161760
[PubMed - indexed for MEDLINE]
Free Article
10.

Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.

Motala AA, Omar MA, Gouws E.

Diabetes Care. 1997 Jul;20(7):1101-7.

PMID:
9203444
[PubMed - indexed for MEDLINE]
11.

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.

Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K.

Diabetes Care. 2009 Mar;32(3):439-44. doi: 10.2337/dc08-1195. Epub 2008 Dec 3.

PMID:
19056613
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?

Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES.

Diabetes Care. 2003 Nov;26(11):3024-30.

PMID:
14578234
[PubMed - indexed for MEDLINE]
14.

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA.

Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.

PMID:
21553243
[PubMed - indexed for MEDLINE]
15.

Cadmium exposure in relation to insulin production, insulin sensitivity and type 2 diabetes: a cross-sectional and prospective study in women.

Barregard L, Bergström G, Fagerberg B.

Environ Res. 2013 Feb;121:104-9. doi: 10.1016/j.envres.2012.11.005. Epub 2012 Dec 20.

PMID:
23261793
[PubMed - indexed for MEDLINE]
16.

Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

J Clin Lab Anal. 2007;21(2):85-90.

PMID:
17385686
[PubMed - indexed for MEDLINE]
17.

Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS).

Lorenzo C, Wagenknecht LE, Rewers MJ, Karter AJ, Bergman RN, Hanley AJ, Haffner SM.

Diabetes Care. 2010 Sep;33(9):2098-103. doi: 10.2337/dc10-0165.

PMID:
20805282
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?

Haffner SM, D'Agostino R Jr, Festa A, Bergman RN, Mykkänen L, Karter A, Saad MF, Wagenknecht LE.

Diabetes Care. 2003 Oct;26(10):2796-803.

PMID:
14514582
[PubMed - indexed for MEDLINE]
19.
20.

Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes.

Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y.

Metabolism. 2004 Jul;53(7):831-5.

PMID:
15254872
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk